AVTR

Avantor, Inc.

$15.57

-2.14%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.

Source: Yahoo Finance
AI summary

Price & performance

1M+9.4%
3M+16.0%
YTD+45.5%
1Y+44.0%
52-week range—
Beta1.01
Full chart and returns against a benchmark

Q-Score

53/ 100

Quality against peers; 50 is the peer median.

Growth49
Risk56
Performance43
Valuation67
Profitability58
Leverage48
Sentiment45
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$6.6B-3.4%
Net income-$530.2M-174.5%
Net margin-8.1%-18.6 pts
Historical fundamentals

Revenue exposure

Largest customer5%
Regions, segments, customers and suppliers

Valuation

AVTRIndustryP/E31.2949.36P/S1.593.73EV/EBITDA15.1923.12P/B1.813.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Oct 28next report, before the open
EPS estimate$0.21
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate